Nasdaq dilutes its biotech index
Article Abstract:
The inclusion of 55 securities to the biotechnology index by Nasdaq Stock Market, New York on November 2003, which made the total companies on the list to 129, and the reflection of this shift on the dynamic nature of biotechnology is discussed. The reclassification of Nasdaq's biotech index according to the definition of biotechnology and pharmaceutical sub-sectors defined by FTSE Group, London is presented.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Biotechs critique big pharma's collaboration skills
Article Abstract:
The overall ranking of pharmaceutical companies on the basis of their collaboration conduct, as perceived by biotech companies is presented. The biotech industry relies on partnering with big pharma for 90% of its funding and hence choosing the right company and tactical approach to negotiations is the key to success.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
G-8 leaders fudge biotech position
Article Abstract:
The eight most economically powerful nations were unable to reach a position on genetically modified foods at their meeting in Okinawa, Japan. Some observers feel that a communique indirectly favors modification by recombinant DNA.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Biotech companies adapt to big pharma mergers. Genzyme acquires Cell Genesys. Demise of the life science company begins
- Abstracts: Italy employs further GMO delay tactics. Italian biotech too reliant on big pharma. Green ag minister wreaks havoc on Italy's agbiotech
- Abstracts: Report recommends ban of US GM maize in Mexico. Survey raises concerns about Bt resistance management. Withdrawn Greenpeace Bt suit enters spin cycle
- Abstracts: Financing bonanza set to continue. AHP sells Immunex stake. Competitive business intelligence gathering and analysis: intelligence systems are providing an answer to the avalanche of information in science and business